Rallybio Corp
RLYB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739410
No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Rallybio Corp changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 34 | 1 | 38 | +5 |
| Shares | 24.1M | 3.03M | 27.4M | +6.40M (+30.5%) |
| Value | $419.9M | $53.2M | $260.1M | −$106.6M (−29.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Rallybio Corp at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TPG GP A, LLC | 3,028,414 | $28.9M | 0.29% |
| Canaan Partners XI LLC | 2,409,712 | $23.0M | 5.92% |
| AJU IB Investment Co., Ltd. | 754,678 | $7.20M | 10.03% |
| Goldman Sachs Group Inc | 13,065 | $125.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 2,914 | $27.0K | 0.00% |
| UBS Group AG | 2,710 | $26.0K | 0.00% |
| Daiwa Securities Group Inc. | 94 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Rallybio Corp at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 61,236 | $1.08M |
| Caas Capital Management LP | 10,000 | $176.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Rallybio Corp at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| TPG Group Holdings (SBS) Advisors, Inc. | 3,028,414 | $53.2M |